MSB 0.64% $1.56 mesoblast limited

Pick Today's Price Range Low-High... Just for Fun, page-1130

  1. 15,788 Posts.
    lightbulb Created with Sketch. 5778
    Oh it's reality you want .... here you go:


    1. FDA supports an accelerated approval pathway for Rexlemestrocel-L, Mesoblast’s allogeneic mesenchymal precursor cell (MPC) product, in patients with end-stage ischemic heart failure with reduced ejection fraction (HFrEF) and a left ventricular assist device (LVAD) for a multi billion dollar blockbuster indication.


    2. Mesoblast have a Pre BLA meeting scheduled with the FDA following the Type B meeting held with FDA on February 21, 2024 whereby the FDA were happy enough with the data from the phase 3 DREAM-HF the LVAD trials to support an Accelerated Approval (AA) pathway.


    (You do understand what a BLA submission is for don't you ?)


    3. Mesoblast secured a multi billion dollar partnership deal for CHF over a decade ago prior to the data from the DREAM-HF phase 3 trial data - you know the same data that the FDA said supports an AA pathway after their Type B meeting.... can you imagine what a CHF partnership deal looks like now with an RMAT Designation and the FDA supporting an AA pathway for same with the Pre BLA meeting happening in the near future?



    https://www.genengnews.com/topics/t...last $130,adult stem cell technology platform.

    Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies


    Deal includes $130 million up front and a $220 million equity payment for a 19.99% stake in Aussie firm.

    Cephalon is paying Mesoblast $130 million up front and will make a $220 million equity investment in the Australian firm as part of a collaboration to develop and commercialize adult mesenchymal precursor stem cell (MPC) therapies based on Mesoblast’s adult stem cell technology platform.




    I could go on but clearly facts are wasted on you as you have a very limited understanding on what the FDA process is or what the developments mean for the company .... I can wait as I didn't invest in Mesoblast for sr-GVHD so if it gets approved it is just a bonus - the CHF indication is where the money is no matter what naysayers like yourself post on HC .... enjoy your day
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.56
Change
-0.010(0.64%)
Mkt cap ! $1.764B
Open High Low Value Volume
$1.56 $1.57 $1.52 $1.590M 1.029M

Buyers (Bids)

No. Vol. Price($)
9 13611 $1.56
 

Sellers (Offers)

Price($) Vol. No.
$1.57 27736 8
View Market Depth
Last trade - 11.45am 18/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.